Wednesday 5th July
Cambridge, UK and Online

Milner Therapeutics Symposium 2023

Symposium Overview

Join us for our 2023 Therapeutics Symposium on Wednesday 5th July, which will once again take place as a hybrid event. A fantastic line-up of speakers will present live at West Road Concert Hall in Cambridge, and talks will be streamed to an online platform. To receive updates on the symposium, including speaker and registration details, please sign up to our events mailing list.

Our Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute partner organisations.

Registration is now open. Click on the button below to register.
If you have any questions about the Symposium, please email



Information for Attendees

The Milner Therapeutics Symposium 2023 will be held as a hybrid event. The in-person event will be held at West Road Concert Hall in Cambridge, and sessions were also live-streamed to an online platform. Registration is free to academics and Milner affiliated companies only.


Oncology   ·   CNS therapeutics   ·   Epigenetics ·   Emerging technologies   ·   Disease-relevant models in target discovery


Serena  Nik-Zainal (Early Cancer Institute, University of Cambridge), Wolf Reik (Altos Labs), Karen Duff (ARUK Drug Discovery Institute, London), Allan Bradley (Cambridge Institute of Therapeutic Immunology & Infectious Disease and Kymab), Cigall Kadoch (Dana Farber Cancer Institute and Harvard Medical School) and Mene Pangalos (AstraZeneca).

More speakers will be announced soon, watch this space! You can read more about our speakers further down this page.


The Symposium will include a poster session featuring the latest research from academia and industry. Details of how to submit a poster abstract will be available on this page soon.

Affiliated Company Overviews

Milner affiliates will shortly be invited to submit a company overview, for inclusion in our symposium booklet. Details of how to submit an overview will be available on this page soon.

Meet the Consortium Session

Registered attendees (academics and affiliated partners) will be able to request a short meeting with pharma companies in the Milner Therapeutics Consortium, during the morning of the Symposium. These non-confidential discussions will be held with a Milner Board member from the company of interest, aimed at identifying collaborative opportunities. Details of how to request one of these meetings will be released soon, registered attendees will receive information by email.



“Targeting the DNA damage response”

Serena Nik-Zainal

Early Cancer Institute
University of Cambridge

“Targeting the DNA damage response”

Wolf Reik

 Altos Labs

“Targeting the DNA damage response”

Karen Duff

ARUK Drug Discovery Institute

“Targeting the DNA damage response”

Allan Bradley

Cambridge Institute of Therapeutic Immunology & Infectious Disease
and Kymab


“Targeting the DNA damage response”

Cigall Kadoch

Dana Farber Cancer Institute
and Harvard Medical School

“Targeting the DNA damage response”

Mene Pangalos


Countdown to #MilnerSymp23